| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |